Literature DB >> 25083891

Diagnosis and prognosis of congenital CMV infection: a case report and review of the literature.

Tiziana Lazzarotto1, Liliana Gabrielli, Brunella Guerra, Francesca Cervi, Giulia Piccirilli, Giuliana Simonazzi, Angela Chiereghin, Francesca Bellini, Maria Paola Landini.   

Abstract

Congenital cytomegalovirus (CMV) infection is the leading non-genetic cause of sensori-neural hearing loss and neurodevelopmental sequelae. Despite these alarming facts, the general public healthcare system is often not aware of CMV and not enough is done to prevent congenital CMV infection.We describe the clinical and laboratory monitoring of a case with primary CMV infection occurring before the first trimester of gestation. Specific literature review is included in order to point out major goals achieved in the diagnosis and prognosis of congenital CMV infection and the many questions still unanswered. Serological diagnosis of primary CMV infection was performed based on serum-CMV specific-IgM antibodies, combined with low avidity anti-CMV IgG antibodies. The maternal infection was asymptomatic, as it is for most infections in immunocompetent patients. Therefore, disclosing primary infection depended on specific serological tests during the initial period of pregnancy (before weeks 12-16 of gestation). The invasive (amniocentesis) and non-invasive (ultrasonographic examination) prenatal tests, carried out at 21 weeks gestation, revealed a severe CMV infection in a fetus small for gestational age with ventriculomegaly. The presence of overt ultrasound abnormalities combined with high viral load in the amniotic fluid sampled at the appropriate times was highly suggestive of an unfavourable prognosis. The autopsy performed on the fetus confirmed severe disseminated CMV infection with histological brain damage.

Entities:  

Keywords:  Human cytomegalovirus; diagnosis and prognosis; pregnancy

Mesh:

Year:  2014        PMID: 25083891     DOI: 10.3109/00365513.2014.936679

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest Suppl        ISSN: 0085-591X


  5 in total

1.  Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.

Authors:  Flavia Chiuppesi; Felix Wussow; Erica Johnson; Chao Bian; Meng Zhuo; Augustine Rajakumar; Peter A Barry; William J Britt; Rana Chakraborty; Don J Diamond
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

2.  Fetal Brain Damage in Human Fetuses with Congenital Cytomegalovirus Infection: Histological Features and Viral Tropism.

Authors:  Giulia Piccirilli; Liliana Gabrielli; Maria Paola Bonasoni; Angela Chiereghin; Gabriele Turello; Eva Caterina Borgatti; Giuliana Simonazzi; Silvia Felici; Marta Leone; Nunzio Cosimo Mario Salfi; Donatella Santini; Tiziana Lazzarotto
Journal:  Cell Mol Neurobiol       Date:  2022-08-07       Impact factor: 4.231

3.  Universal Newborn Screening for Congenital Cytomegalovirus Infection - From Infant to Maternal Infection: A Prospective Multicenter Study.

Authors:  Angela Chiereghin; Claudia Pavia; Gabriele Turello; Eva Caterina Borgatti; Federico Baiesi Pillastrini; Liliana Gabrielli; Dino Gibertoni; Concetta Marsico; Massimo De Paschale; Maria Teresa Manco; Antonia Ruscitto; Laura Pogliani; Marta Bellini; Alessandro Porta; Luciana Parola; Maria Luisa Scarasciulli; Agata Calvario; Manuela Capozza; Maria Grazia Capretti; Nicola Laforgia; Pierangelo Clerici; Tiziana Lazzarotto
Journal:  Front Pediatr       Date:  2022-07-06       Impact factor: 3.569

4.  Cytomegalovirus establishes a latent reservoir and triggers long-lasting inflammation in the eye.

Authors:  Valentina Voigt; Christopher E Andoniou; Iona S Schuster; Anna Oszmiana; Monique L Ong; Peter Fleming; John V Forrester; Mariapia A Degli-Esposti
Journal:  PLoS Pathog       Date:  2018-05-31       Impact factor: 6.823

Review 5.  CMV-Specific Cell-Mediated Immunity in Immunocompetent Adults with Primary CMV Infection: A Case Series and Review of the Literature.

Authors:  Angela Chiereghin; Gabriella Verucchi; Tiziana Lazzarotto
Journal:  Viruses       Date:  2021-05-01       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.